Phase III randomized placebo-controlled trial of two doses of megestrol acetate as treatment for menopausal symptoms in women with breast cancer: Southwest Oncology Group Study 9626.

Publication Type:

Journal Article

Source:

Journal of clinical oncology : official journal of the American Society of Clinical Oncology, Volume 26, Issue 10, p.1650-6 (2008)

Keywords:

2008, Aged, Antineoplastic Agents, Hormonal, Breast Neoplasms, Female, Hot Flashes, Humans, Megestrol Acetate, Menopause, Middle Aged, Placebos, Public Health Sciences Division, Tamoxifen

Abstract:

Prior progestin studies treating hot flashes in women have been short duration and single dose. This study tests the progestin megestrol acetate (MA) at two doses versus placebo over 6 months.